Cozaar

ApprovedSmall molecule

Teva

Cozaar is one of 39 small molecule programs targeting Liver Transplant. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Liver TransplantActive, not recruiting

Bicuspid Aortic ValveActive, not recruiting

Liver TransplantApproved

Active, not recruiting

Bicuspid Aortic ValvePreclinical

Active, not recruiting

Competition

Competitive Landscape

353 competitors in Liver Transplant

#DrugCompanyPhaseTrials

Cozaar

Teva

Approved

1 2

Vemlidy

Gilead

Preclinical

3 3

Cysteine Hydrochloride

Novartis

Preclinical

3 4

Lenvima

Eisai

Preclinical

2 5

Octreotide

Johnson & Johnson

Preclinical

2 6

Beyfortus

BeiGene

Preclinical

1 7

Prostigmin

Merck & Co.

Preclinical

1 8

Myfortic

Novartis

Preclinical

1 9

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

4 10

Myfortic

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fasting Conditions3 trials

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Completed· Teva logo

Teva·Phase 1·NCT01124175·80 enrolled

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Completed·PPharmtechnology LLC·Phase 1·NCT03459911·66 enrolled

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Completed· Teva logo

Teva·Phase 1·NCT01124162·80 enrolled

Liver Transplant1 trial

The Effects of Angiotensin II Receptor Blockade on Kidney Function and Scarring After Liver Transplant

Completed·MMayo Clinic·Phase 4·NCT00275639·62 enrolled

Bicuspid aortic valve1 trial

The Effect of Losartan in Bicuspid Aortic Valve Patients

Terminated·UUniversity of Michigan·N/A·NCT01390181·4 enrolled

Function1 trial

The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney

Completed·MMansoura University·N/A·NCT04278495·96 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Cozaar. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Cozaar compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Cozaar. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Teva company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Teva

Cozaar

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Fasting Conditions3 trials

Liver Transplant1 trial

Bicuspid aortic valve1 trial

Function1 trial

References

Drug Info

Quick Facts

Related News